These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 39175020)

  • 1. Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer.
    Zhao L; Cheng H; Tong Z; Cai J
    J Nanobiotechnology; 2024 Aug; 22(1):504. PubMed ID: 39175020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-induced cell pyroptosis to enhance antitumor immunotherapy.
    Ge J; Zhang Z; Zhao S; Chen Y; Min X; Cai Y; Zhao H; Wu X; Zhao F; Chen B
    J Mater Chem B; 2024 Apr; 12(16):3857-3880. PubMed ID: 38563315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy.
    Wu D; Wang S; Yu G; Chen X
    Angew Chem Int Ed Engl; 2021 Apr; 60(15):8018-8034. PubMed ID: 32894628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boarding pyroptosis onto nanotechnology for cancer therapy.
    Ban W; Chen Z; Zhang T; Du T; Huo D; Zhu G; He Z; Sun J; Sun M
    J Control Release; 2024 Jun; 370():653-676. PubMed ID: 38735396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy.
    Ji F; Shi C; Shu Z; Li Z
    Int J Nanomedicine; 2024; 19():5545-5579. PubMed ID: 38882539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroptosis in inflammatory diseases and cancer.
    Rao Z; Zhu Y; Yang P; Chen Z; Xia Y; Qiao C; Liu W; Deng H; Li J; Ning P; Wang Z
    Theranostics; 2022; 12(9):4310-4329. PubMed ID: 35673561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy.
    Zhang Z; Zhou Y; Zhao S; Ding L; Chen B; Chen Y
    Adv Sci (Weinh); 2022 Dec; 9(35):e2203583. PubMed ID: 36266982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis and pyroptosis-inducing cancer drugs.
    Yang F; Bettadapura SN; Smeltzer MS; Zhu H; Wang S
    Acta Pharmacol Sin; 2022 Oct; 43(10):2462-2473. PubMed ID: 35288674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pyroptosis in cancer and its therapeutic regulation.
    Al Mamun A; Mimi AA; Aziz MA; Zaeem M; Ahmed T; Munir F; Xiao J
    Eur J Pharmacol; 2021 Nov; 910():174444. PubMed ID: 34453928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Pyroptosis: A Promising Strategy for Cancer Treatment.
    Wang L; Qin X; Liang J; Ge P
    Front Oncol; 2021; 11():635774. PubMed ID: 33718226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment.
    Li M; Jiang P; Yang Y; Xiong L; Wei S; Wang J; Li C
    Exp Hematol Oncol; 2023 Dec; 12(1):103. PubMed ID: 38066523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-therapeutics: The upcoming nanomedicine to treat cancer.
    Khan H; Shahab U; Alshammari A; Alyahyawi AR; Akasha R; Alharazi T; Ahmad R; Khanam A; Habib S; Kaur K; Ahmad S; Moinuddin
    IUBMB Life; 2024 Aug; 76(8):468-484. PubMed ID: 38440959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pyroptotic cell death as a potential tool for cancer treatment.
    Faria SS; Fernando AJ; de Lima VCC; Rossi AG; de Carvalho JMA; Magalhães KG
    J Inflamm (Lond); 2022 Nov; 19(1):19. PubMed ID: 36376979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Incorporated Nanomedicines for Cancer Therapy.
    Wu SY; Wu FG; Chen X
    Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.
    Lu H; Zhang S; Wu J; Chen M; Cai MC; Fu Y; Li W; Wang J; Zhao X; Yu Z; Ma P; Zhuang G
    Clin Cancer Res; 2018 Dec; 24(23):6066-6077. PubMed ID: 30061362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway.
    Feng Z; Chen G; Zhong M; Lin L; Mai Z; Tang Y; Chen G; Ma W; Li G; Yang Y; Yu Z; Yu M
    Biomaterials; 2023 Nov; 302():122333. PubMed ID: 37738743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroptosis: A promising therapeutic target for noninfectious diseases.
    Li T; Zheng G; Li B; Tang L
    Cell Prolif; 2021 Nov; 54(11):e13137. PubMed ID: 34590363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.